Abstract |
The effect of antimalarial drugs on immune responses to the malaria infection is evaluated in vivo using two experimental self-cured rodent models. BALB/c and DBA/2 mice were infected by Plasmodium yoelii 17XNL and 17XL strains, respectively, and then treated with different doses of antimalarial drugs: chloroquine (228mg/kg or 114mg/kg of the body weight) or artesunate (78mg/kg or 39mg/kg). The effect of antimalarial drugs on host immune responses was evaluated by parasitemia, splenocyte IFN-gamma production level, and parasite-specific IgG level in the serum, however, no significant differences were observed between drug-treated and untreated groups. Moreover, most of the infected mice of all groups showed the ability to resist homologous reinfection (challenged on day 60 post- infection), only a few mice experienced transient, low parasitemia. The rechallenged mice were accompanied by high level of parasite-specific IgG. Therefore, this research implicated that, for BALB/c and DBA/2 mice, chloroquine or artesunate treatment of blood-stage P. yoelii infections does not compromise acquired immunity to malaria in either primary infection or upon rechallenge.
|
Authors | Shi-Hong Ma, Li Zheng, Ying-Jie Liu, Sheng-Yu Guo, Hui Feng, Guang Chen, Dong-Mei Li, Ji-Chun Wang, Ya-Ming Cao |
Journal | Experimental parasitology
(Exp Parasitol)
Vol. 116
Issue 3
Pg. 266-72
(Jul 2007)
ISSN: 0014-4894 [Print] United States |
PMID | 17336298
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Protozoan
- Antimalarials
- Artemisinins
- Immunoglobulin G
- Sesquiterpenes
- Artesunate
- Interferon-gamma
- Chloroquine
|
Topics |
- Animals
- Antibodies, Protozoan
(biosynthesis, blood)
- Antimalarials
(pharmacology)
- Artemisinins
(pharmacology)
- Artesunate
- Chloroquine
(pharmacology)
- Female
- Immunoglobulin G
(biosynthesis, blood)
- Interferon-gamma
(analysis)
- Malaria
(drug therapy, immunology)
- Mice
- Mice, Inbred BALB C
- Mice, Inbred DBA
- Parasitemia
(drug therapy, immunology, parasitology)
- Plasmodium yoelii
(drug effects, immunology)
- Recurrence
- Sesquiterpenes
(pharmacology)
|